The Most Favoured Nation (MFN) trade policy is reshaping India’s pharmaceutical industry by enabling smoother supply chains and expanding global market access. Through reduced tariffs and equal trade terms, India is strengthening its position as a leading supplier of affordable medicines worldwide, while facing new opportunities and challenges in an increasingly competitive landscape.